Osteoarthritis Trial, Recruiting (NCT05823727)

Osteoarthritis Trial, Recruiting NCT05823727 Sponsor: University of Arkansas Condition: Osteoarthritis

Printed from Voxsanity (voxsanity.com.au) — NCT05823727 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Osteoarthritis

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People between 50 and 75 years old, of any sex
People with a body mass index (a measure of body weight relative to height) between 20.0 and 39.9
People who have been diagnosed with primary osteoarthritis (joint damage caused by wear and tear, not another condition)
People who are scheduled to have a total knee replacement surgery at UAMS approximately two months before that surgery takes place
People who live near Little Rock and are able to attend physical therapy sessions in Little Rock
People who have tested negative for COVID-19 or are not showing any COVID-19 symptoms

Who may not be able to join:

People who have previously had a serious knee injury or surgery to the ACL (a ligament in the knee) in the knee scheduled for replacement
Women who have not yet gone through menopause
People who have used hormone replacement therapy at any point in the last 12 months
People who currently have an active diagnosis of a blood-borne infectious disease (an illness spread through the blood, such as HIV or hepatitis — confirm with trial site for specific conditions included)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 8 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 619-677-0792

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT05823727

Sponsor: University of Arkansas

Phase: Not Applicable

Status: Recruiting

Condition: Osteoarthritis

Trial contact: 619-677-0792

More information: https://clinicaltrials.gov/study/NCT05823727

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People between 50 and 75 years old, of any sex
People with a body mass index (a measure of body weight relative to height) between 20.0 and 39.9
People who have been diagnosed with primary osteoarthritis (joint damage caused by wear and tear, not another condition)
People who are scheduled to have a total knee replacement surgery at UAMS approximately two months before that surgery takes place
People who live near Little Rock and are able to attend physical therapy sessions in Little Rock
People who have tested negative for COVID-19 or are not showing any COVID-19 symptoms

Who may not be able to join:

People who have previously had a serious knee injury or surgery to the ACL (a ligament in the knee) in the knee scheduled for replacement
Women who have not yet gone through menopause
People who have used hormone replacement therapy at any point in the last 12 months
People who currently have an active diagnosis of a blood-borne infectious disease (an illness spread through the blood, such as HIV or hepatitis — confirm with trial site for specific conditions included)

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 8 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

University of Arkansas

Registry

ClinicalTrials.gov

Start date

1 May 2026

Est. completion

1 June 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Effects of pre-surgical supplementation on mRNA transcription

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 8 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov